Clinical Trial Update: A Pharmacokinetic Study of Genistein, a Tyrosine Kinase Inhibitor [Phase 1]

View source ↗

Summary

The document reports the completion of a Phase 1 pharmacokinetic study of genistein, a tyrosine kinase inhibitor, in cancer patients. The study evaluated the ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Genistein (genistein)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Cancer | Phase 1 | Status: COMPLETED